Form 483

GC Hanford Manufacturing Company Form 483, 2016-12-16

FDA issued a Form 483 to GC Hanford Manufacturing Company on 2016-12-16 with 12 public-safe observations.

483· Form 483 issuedHuman Drugs12 observations

GC Hanford Manufacturing Company · Syracuse, United States · Issued December 16, 2016

Overview

  • 12 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 Dec 2016
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Anastasia M Shields, Junho Pak

16 Dec 2016
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Anastasia M Shields, Junho Pak

16 Dec 2016
21 CFR 211.160(b)(4)

Calibration - at intervals, written program, remedial action

Cited by Anastasia M Shields, Junho Pak

16 Dec 2016
21 CFR 211.160(b)(4)

Calibration - at intervals, written program, remedial action

Cited by Anastasia M Shields, Junho Pak

16 Dec 2016
21 CFR 211.186(b)(9)

Complete instructions, procedures, specifications et. al.

Cited by Anastasia M Shields, Junho Pak

Inspected site

GHGC Hanford Manufacturing CompanySyracuse, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations2x
21 CFR 211.186(b)(9)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)(7)Cited across public-safe Form 483 observations2x
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 12 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere